Ovarian cancer rates decline in Czech Republic due to genetic testing

Ovarian cancer cases in the Czech Republic have decreased by nearly 20 percent over the last 20 years. According to the National Cancer Registry, new diagnoses dropped from 1,212 cases in 2004 to 952 in 2024.

Medical experts attribute this decline to improved preventive measures, including regular screenings for women aged 25 to 45 and enhanced interdisciplinary cooperation with oncologists. A critical component of prevention is genetic testing, which identifies hereditary risks in patients and their relatives. For women with a proven genetic predisposition, doctors can recommend preventive removal of ovaries and fallopian tubes before cancer develops.

To expand these services, the General University Hospital in Prague is opening a new medical genetics outpatient clinic at the Clinic of Gynecology, Obstetrics, and Neonatology at Apolinář.